Lundquist Researcher Presents Final EVAPORATE Results That Show Icosapent Ethyl Significantly Reduces Coronary Plaque

Matthew Budoff, MD presented the EVAPORATE results at the ESC Congress 2020 on August 29, 2020, with concurrent publication in the European Heart Journal

LOS ANGELES — Today, The Lundquist Institute announced that Matthew Budoff, MD, Director of Cardiovascular CT at the Institute and Professor of Medicine at the David Geffen School of Medicine at UCLA, will present the final results of the EVAPORATE study at ESC Congress 2020 (organized by the European Society of Cardiology) with concurrent publication in the European Heart Journal.

NIH Awards $2.3 Million to The Lundquist Institute to Study the Impact of Vaping While Pregnant

Study will allow The Lundquist Institute to determine the multi-generational risks of developing asthma from vaping while pregnant

LOS ANGELES - Studies have shown that pregnant women who smoke increase the risk of their children having asthma, and that those children—even if non-smokers—can pass it on to their own children, but few objective studies have evaluated the effects of vaporized nicotine and vapor flavorings. Investigators from The Lundquist Institute, under the leadership of Virender Rehan, MD, have received a $2.3 million grant from the National Institutes of Health (NIH) to research this multi-generational effect of vaping, or smoking an electronic cigarette, while pregnant.